Antonio Gómez Caamaño-rekin lankidetzan egindako argitalpenak (2)

2015

  1. The metabolic syndrome and its components in patients with prostate cancer on androgen deprivation therapy

    Journal of Urology, Vol. 193, Núm. 6, pp. 1963-1969

2013

  1. Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study

    British Journal of Cancer, Vol. 108, Núm. 12, pp. 2565-2572